| Literature DB >> 34949747 |
Ju Hyun Nam1, JeongUn Choi1, Chaiwat Monmai2, Weerawan Rod-In2, A-Yeong Jang1, SangGuan You1,2, Woo Jung Park1,2.
Abstract
Panax ginseng C. A. Meyer is well known as traditional herbal medicine, and ginseng berries are known to exhibit potential immune-enhancing functions. However, little is known about the in vivo immunomodulatory activity of Korean ginseng berries. In this study, crude Korean ginseng berries polysaccharides (GBP) were isolated and their immunomodulatory activities were investigated using cyclophosphamide (CY)-induced immunosuppressive BALB/c mice. In CY-treated mice, oral administration of GBP (50-500 mg/kg BW) remarkably increased their spleen sizes and spleen indices and activated NK cell activities. GBP also resulted in the proliferation of splenic lymphocytes (coordinating with ConA: plant mitogen which is known to stimulate T-cell or LPS: endotoxin which binds receptor complex in B cells to promote the secretion of pro-inflammatory cytokines) in a dose-dependent manner. In addition, GBP significantly stimulated mRNA expression levels of immune-associated genes including interleukin-1β (IL-1β), IL-2, IL-4, IL-6, tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), toll-like receptor 4 (TLR-4), and cyclooxygenase-2 (COX-2) in CY-treated mice. These results indicate that GBP is involved in immune effects against CY-induced immunosuppression. Thus, GBP could be developed as an immunomodulation agent for medicinal or functional food application.Entities:
Keywords: Korean ginseng berry; cyclophosphamide; immune-enhancing effect; polysaccharides
Mesh:
Substances:
Year: 2022 PMID: 34949747 DOI: 10.4014/jmb.2110.10021
Source DB: PubMed Journal: J Microbiol Biotechnol ISSN: 1017-7825 Impact factor: 2.351